Genethera inc
WebMar 24, 2024 · GeneThera, Inc. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. GeneThera, Inc.’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. There are not analysts providing consensus earnings estimates for the current fiscal year. WebGeneThera is a biotechnology company, dedicated to improving food safety by applying the latest molecular technologies to eradicate "cross over" (zoonotic) diseases such as … GeneThera is a biotechnology company, dedicated to improving food safety by … GeneThera’s molecular assay is designed to be implemented using a modular unit … Ms. Irizarry served as Vice President for Genetrans, Inc. from 1994 until 1998. In … GeneThera provides a comprehensive Johne’s solution that allows to diagnose, … Applied Genetics, a majority owned subsidiary of Genethera Inc. is a … JOHNE’S FACTS. Johne's Disease targets all ruminates. Johne's Disease (JD) is a … JOHNE’S DISEASE AND CROHN’S . An overwhelming number of studies point to … © 2011 GeneThera Inc. Access our latest filings on the U.S. Securities and Exchange Commission … Tannya Irizarry GeneThera, Inc. 7577 W. 103rd Ave, Ste 212 Westminster, CO …
Genethera inc
Did you know?
WebAug 15, 2008 · GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, CO. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression system, GES, a protocol … WebOct 12, 2024 · GeneThera is a biotechnology company developing molecular robotic/AI diagnostics and therapeutics in an effort to control and eradicate zoonotic diseases. …
WebApr 14, 2024 · All news about GENETHERA, INC. 02/01: Genethera inc - 10-k/a - AQ. 2024: Genethera Inc : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF.. AQ. 2024: GeneThera, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Se.. CI. 2024: WebMay 18, 2024 · About GeneThera, Inc. GeneThera is a biotechnology company developing molecular robotic/AI diagnostics and therapeutics in an effort to control and eradicate zoonotic diseases. GeneThera developed molecular assays for BSE and Mycobacterium Avium Paratuberculosis (MAP). MAP is an infectious organism causing Paratuberculosis …
WebMar 15, 2024 · GeneThera, Inc. is a biotechnology company that focuses on eradicating zoonotic diseases such as COVID-19 (Novel Coronavirus), Paratuberculosis (Johne’s disease), Mad Cow Disease, Chronic ... WebApr 27, 2024 · WESTMINSTER, Colo., April 27, 2024 (GLOBE NEWSWIRE) -- GeneThera announced today that it has entered into a partnership agreement with Cumming Corporation, a privately held international project consulting firm, specialized in the healthcare sector company.The partnership with Cumming Corporation will allow …
WebGeneThera 660 followers on LinkedIn. Developing diagnostic tests and vaccines for zoonotic diseases. GeneThera is a fully reporting publicly traded biotechnology company (OTC: GTHR) that ...
WebGeneThera’s molecular assay is designed to be implemented using a modular unit concept that allows the operator to perform the entire procedure of DNA extraction and analysis within a closed, computerized and highly flexible robotic system. It represents a great advantage over other available systems because of its greater sensitivity, speed ... johnstone renfrewshire scotlandWebgenethera inc Analyst Report: Johnson & Johnson Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: … johnstone ritchieWebMay 18, 2024 · About GeneThera, Inc. GeneThera is a biotechnology company developing molecular robotic/AI diagnostics and therapeutics in an effort to control and eradicate zoonotic diseases. johnstone river community gardensWebJan 25, 2012 · WESTMINSTER, Colo., Jan. 25, 2012 /PRNewswire/ -- GeneThera, Inc. (OTCQB: GTHR) announced today that it has acquired a majority ownership of Applied Genetics, a molecular diagnostic company based ... johnstone renfrewshire train stationWebGeneThera is a biotechnology company, dedicated to improving food safety by applying the latest molecular technologies to eradicate "cross over"(zoonotic) diseases such as Johne's Disease, Mad Cow Disease, Chronic Wasting Disease, and E.coli. Diseases of terrestrial, avian and aquatic life animals influence a number of economic and ... how to go to app labWebErkenne unterbewertete Aktien mit einem Blick Eulerpool Research Systems ... English ... ... how to go to app settings heyzapWebSep 22, 2009 · ARVADA, CO--(Marketwire - September 22, 2009) - GeneThera, Inc. (PINKSHEETS: GTHR), an international biotechnology company, today announced it has finalized a license and research agreement with two Italian universities: Universita di Roma "Tor Vergata" (UNIROMA2) and Universita Cattolica del Sacro Cuore (UCSC).The … how to go to applications on mac